IP Verse

Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material

Patent No. EP2945962 (titled "Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material") was filed by Prothera Biologics on Jan 17, 2014. The application was issued on Apr 17, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOTESTJan 17, 2020MORE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2945962

PROTHERA BIOLOGICS
Application Number
EP14740523A
Filing Date
Jan 17, 2014
Status
Revoked
Jun 23, 2023
Publication Date
Apr 17, 2019
External Links
Slate, Register , Google Patents